Available Technology
Techniques for high yield synthesis of macrocyclic compounds
Technology:
New process using of a solid-phase resin to synthesize macrocycle compounds
Markets Addressed
Non-exhaustively, macrocycles prepared using this method have useful pharmaceutical applications as anti-tumor agents (epithilone, rapamycin), anti-bacterials (vancomycin, erythromycin), statins (lovastatin), immunosuppressants (cyclosporin A), and anti-fungals (soraphen, fengycin) Because many bioactive molecules are macrocycles, the generation of a diverse library of compounds followed by biological screening would be an attractive drug discovery strategy.
Innovations and Advantages
Many useful pharmaceuticals, including natural products, have a macrocyclic structure that can be a challenge when exploring synthesis methods. The Walsh Laboratory has discovered a new process using of a solid-phase resin to synthesize macrocycle compounds, including polyketide synthase (PKS), non-ribosomal peptide synthetase (NRPS) and fatty acid synthase (FAS). The peptidic precursor molecules are connected to the solid-phase resin using a specific linker, and macrocyclization is achieved using a Type I thioesterase domain (TE) excised from a NRPS or PKS. The thioesterase catalyzes cyclization on the deprotected, resin-bound peptidic molecule, while concomitantly cleaving the linear peptide from the resin. The process results in a high yield, high specificity macrocyclic compound.
Additional Information
Intellectual Property Status: Issued U.S. patent nos.: 7,279,304
Tweet
Inventor(s):
Burkart, Michael D.
Kohli, Rahul M.
Marahiel, Mohamed A.
Mootz, Henning D.
Schwarzer, Dirk
Trauger, John W.
Walsh, Christopher T.
Categories:
For further information, please contact:
Grant Zimmermann, Director of Business Development
(617) 495-3067
Reference Harvard Case #1781